Mercer Global Advisors
HCAT icon

Mercer Global Advisors’s Health Catalyst HCAT Stock Holding History

Mercer Global Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Buy
+6,855
New +$9.9K ﹤0.01% 5006

Other funds holding HCAT

Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mercer Global Advisors's HCAT Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Health Catalyst (HCAT) in Q2 2026: 6,855 shares worth $13.6K. The stake represents ﹤0.01% of the portfolio and ranks #5006 among its holdings.

91 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Mercer Global Advisors held 6,855 shares of Health Catalyst worth $13.6K as of Q2 2026.
  • Health Catalyst was a new Mercer Global Advisors position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5006 holding.
  • 91 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.